Avara was founded and is led by a team of industry veterans who have significant knowledge and experience with pharmaceutical manufacturing and technical services.
Chairman, Chief Executive Officer
Tim Tyson – a global leader in the pharmaceutical industry – is Chairman and CEO of Avara Pharmaceutical Services. In his 35-plus year career, Mr. Tyson has negotiated complex multi-billion dollar mergers and acquisitions, led major turnarounds that have fueled growth and value, and most significantly, has been instrumental in bringing more than 50 life-saving and life-improving medicines to market. He was previously Chairman and CEO of Aptuit. From 2002-2008, he served as CEO at Valeant Pharmaceuticals International. Prior to that, he was at GlaxoSmithKline for almost 15 years, initially in engineering, then in many positions in Commercial Operations, then as President of GSK’s Global Manufacturing & Supply division.
Mr. Tyson began his business career as a manufacturing manager at Procter & Gamble after completing full-time military service. He is a graduate of the United States Military Academy at West Point and received his M.B.A. from Jacksonville State University.
Avara has a world-class team of pharmaceutical executives managing operations, quality, human resources, commercial operations and finance – all of whom have worked with Mr. Tyson previously.
Executive Vice President, Chief Operating Officer
Jim Scandura has a wealth of pharmaceutical industry experience through projects with i-Solutions – a Life Sciences specialty consulting company. He has managed three major pharmaceutical manufacturing network change programs, three consent decree recovery efforts, over 30 manufacturing site audit and operational improvement efforts, integration of a large R&D center, the direct management and integration of several manufacturing sites. Mr. Scandura has experience working for Bristol Meyers Squibb, GSK, Roche, Valeant, Patheon, Aptuit and many other pharmaceutical companies. Previously, he was Senior Vice President at Johnson Controls Inc. and, prior to that, served in the U.S. Navy Nuclear Submarine Service.
Executive Vice President, Chief Financial Officer
Keith Lyon has over 35 years of experience in operational and transactional finance, both in leading multinationals and smaller companies.
He began his career at Nestle in the United States and Brazil. Subsequently, he was a senior corporate banker in New York. As Corporate Treasurer at Duracell, he built a global treasury organization and held the same position at Estee Lauder. In these roles, he completed many financings, debt offerings and two initial public offerings.
He was an Operating Partner in private equity, acquiring Wise Snacks and serving as interim CFO. As CEO of a community bank, he led a financial and regulatory recovery and negotiated a merger with a larger institution.
Mr. Lyon received his Bachelor of Arts from the University of Leeds and his M.B.A. from the Booth School of Business at the University of Chicago.
Executive Vice President, Chief Commercial Officer
Bill Pasek has over 25 years of experience in sales leadership roles. He served as Director of Sales, Regional Vice President and most recently as National Business Director for Quintiles, and has managed and led sales teams ranging from 90 to 450 salespeople. He is a consummate leader in the pharmaceutical industry.
Mr. Pasek started his pharmaceutical career with GSK, where he helped build and lead the dermatology division and established GSK as the most admired company in that therapeutic category. During his time at GSK, he launched 11 brands in the dermatology market. In 2002, he joined Sepracor, which later became Sunovion.
He was a founding member of the Sepracor commercial team and was instrumental in deciding the overall size and structure of the Sepracor sales team. During this time, he helped the organization grow from $200M in sales to $1.4B. He played a significant role in the launch strategy and execution of Lunesta – one of the top 10 pharmaceutical launches at the time.
Mr. Pasek has a degree in Business Economics from the University of Southern Connecticut.
Chief Human Resources Officer
Rick Mark's career has spanned five industries, including pharmaceuticals, distribution, consumer products, pharmaceutical services and nuclear power generation. During his career, Mr. Mark has led human resources due diligence/integration efforts resulting in acquisitions valued at $1 billion, and covering 10,000 employees in 40 countries.
He has extensive experience in change management, mergers and acquisitions, and leadership development. In previous HR roles, he led safety, health, and facilities departments in addition to human resources for global organizations. Mr. Mark is also a recognized public speaker on workplace violence prevention.
Mr. Mark has a Bachelor of Arts from the University of North Carolina at Chapel Hill.
Executive Vice President Global Planning and Supply
Mike Kays has extensive experience in project management, supply chain, operations, and customer stewardship. He has built strong relationships and has recognized expertise across multiple industries, including process equipment, cryogenics, cold chain technology, and pharmaceutical manufacturing, including isolation and high containment systems.
His career responsibility progressed from engineering through global operations leadership. Mike served as CEO for a leading supplier of custom design/build equipment for major pharmaceutical customers across the Americas, Europe, and Asia. He then became Senior Vice President of Global Supply for Valeant Pharmaceuticals, leading a manufacturing restructuring and global outsourcing initiative. He later joined Aptuit, Inc. as Executive Vice President of Global Operations Planning, including Client Project Management, Technical Proposals, and Global Procurement.
Mr. Kays holds a B.S. degree from Alfred University in New York. He is a past board member of the ISPE International Leadership Forum, and remains a Board member and executive advisor to various academic and business interests.
Executive Vice President Global Quality Assurance and Regulatory Affairs
Warren has 35 years of industry experience with a broad pharmaceutical background and extensive experience in manufacturing management, quality assurance, quality control and operational excellence. He joined Abbott Laboratories and the pharmaceutical industry in 1986 and has had successive levels of leadership and responsibility in manufacturing and quality assurance. Warren has experience in new plant start-ups, remediation of consent decrees and warning letters, quality system integration and data integrity remediation. He has worked for Abbott Labs, Alpharma, DSM and Patheon in manufacturing and quality leadership roles up to VP, Global Quality at Patheon.
Warren is a graduate of Southeast Missouri State University.
EVP Chief Information Officer
Charlie Lickfold is an IT leader with extensive experience in IT transformations, corporate M&A, and business change programs. He was previously CIO for Gilbarco Veeder-Root (GVR), where he led the IT transformation and support of new technology product innovation.
Prior to his time at GVR, Mr. Lickfold spent 17 years in the pharmaceutical industry. He held numerous IT leadership positions including Vice President, Head of Global IT at Patheon Pharmaceuticals where he successfully established and supported global quality, manufacturing, lab and business systems. Prior to that, he was Senior Director of IT at Valeant Pharmaceuticals responsible for the company’s SAP center of excellence as well as the transition to a new set of global IT services for network, datacenter, end user computing.
Mr. Lickfold began his career as a management consultant in the life sciences practice for Ernst & Young LLP. He has a Bachelor of Science in Computer Science from the University of Kentucky.
EVP Operational Excellence
Mark is a seasoned operations and general management executive. Over the last 28 years of his career he has gained a wide range of experience across the pharmaceutical industry, including discovery, development, drug substance and drug product manufacturing for clinical and commercial supply, supply chain, and logistics.
Prior to joining Avara this year, Mark held executive roles at GlaxoSmithKline, Valeant, Aptuit, and more recently Marken. For the first ten years of his career, he managed major capital engineering and construction projects at Exxon.
Mark has led global, regional and local operations and technical support functions, driven strategic change, and deployed Operational Excellence programs in four companies. He spent 12 years as an expatriate in several locations in Europe, lived and worked in multiple cities in the United States, and conducted business around the world. Mark has experience on both the client and the supplier side of the industry.
He holds a B.S.C.E degree from Lehigh University and is a licensed Professional Engineer.